Last reviewed · How we verify
SA55 nasal spray — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
SA55 nasal spray (SA55 nasal spray) — Sinovac Life Sciences Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SA55 nasal spray TARGET | SA55 nasal spray | Sinovac Life Sciences Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SA55 nasal spray CI watch — RSS
- SA55 nasal spray CI watch — Atom
- SA55 nasal spray CI watch — JSON
- SA55 nasal spray alone — RSS
Cite this brief
Drug Landscape (2026). SA55 nasal spray — Competitive Intelligence Brief. https://druglandscape.com/ci/sa55-nasal-spray. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab